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Introduction: There are few data about possible interaction of sex hormones and thyroid 
autoimmunity and function in women with Hashimoto’s thyroiditis (HT) after menopause. 
Therefore, our aim was to investigate sex hormone levels in euthyroid (EuHT) and 
hypothyroid (HypoHT) postmenopausal women with HT. 
Material and methods: We performed a prospective observational clinical study that 
included 55 women with HT (AllHT) and 18 healthy subjects (HS) after menopause matched 
by age, body mass index, follicle-stimulating hormone, and menopause duration. According 
to their thyrotropin (TSH) level, the AllHT patients were divided into two subgroups: EuHT 
with TSH in the range 0.35–5.5 mU/L and HypoHT with TSH above 5.5 mU/L. Total and 
free testosterone (T), sex hormone-binding globulin (SHBG), oestradiol (E2), and 
progesterone (P) were measured in all subjects. Values are presented as mean ± SD. The 
Mann-Whitney U test was used for comparison of values between the groups. Correlations 
were tested using Kendall’s tau test. 
Results: In the HypoHT group, significantly higher free T levels were found in comparison 
to the HS group (7.89 ± 3.55 pmol/L and 7.13 ± 3.03 pmol/L, p < 0.05). Furthermore, in 
HypoHT, free T was significantly higher than in EuHT (7.19 ± 5.65 pmol/L, p < 0.05). 
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SHBG was significantly lower in HypoHT compared with HS (45.4 ± 17.4 nmol/L and 60.09 
± 19.51 nmol/L, p < 0.05). No significant correlation was found between sex hormone levels 
and antiTg and antiTPO antibodies. 
Conclusion: We report significantly higher free and total T levels in hypothyroid 
postmenopausal women with HT. To our knowledge, this is the first study of sex hormone 
levels in postmenopausal women with HT. 
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Introduction 
Hashimoto's thyroiditis (HT) is a common autoimmune thyroid disorder, which is more 
prevalent in women than in men [1]. The female predominance of HT increases sharply 
during puberty [2], and the prevalence is also higher in patients with polycystic ovary 
syndrome [3], both suggesting a possible role of sex hormones in the pathogenesis of the 
disease. After menopause, attenuation of sex hormone influence on autoimmunity would be 
expected. However, the prevalence of HT in women increases with age [1]. An effect of 
physiological menopause on circulating androgen levels has not been observed [4]. Several 
associations between menopause and autoimmune diseases other than HT have been reported 
[4]. There are no published studies investigating sex hormone levels in euthyroid and 
hypothyroid women with HT in the menopause. Therefore, our aim was to investigate sex 
hormone levels in euthyroid and hypothyroid postmenopausal women with HT. 
 
Material and methods 
In this prospective observational clinical study, 55 postmenopausal women with HT and 18 
healthy postmenopausal women were included. The protocol of the study was approved by 
the Republic of Slovenia National Medical Ethics Committee (number 84/05/13).  
Menopause was confirmed by the absence of menses during the preceding 12-month interval 
and an elevated follicle-stimulating hormone (FSH) above 20 U/L. Healthy women in the 
control group had thyrotropin (TSH) in the range 0.35–5.5 mU/L, isoechoic thyroid 
ultrasound pattern, and normal levels of antibodies against thyroid peroxidase (TPOAb) and 
thyroglobulin (TgAb). HT was diagnosed by hypoechoic thyroid ultrasound pattern and 
elevated levels of TPOAb and/or TgAb. According to TSH level, patients with HT (AllHT) 
were divided into euthyroid HT with TSH in the normal range (EuHT) (n = 34) and 
hypothyroid HT with TSH level above 5.5 mU/L (HypoHT) (n = 21). Evaluation of sex 
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hormones included measurement of FSH, total and free testosterone (T), oestradiol (E2), 
progesterone (P), and sex hormone-binding globulin (SHBG).  
Women taking hormone replacement therapy for menopausal symptoms or women suffering 
from any acute infection or other serious illness were not included in the study.  
All laboratory measurements were performed in the Laboratory for Clinical Biochemistry and 
Radiochemistry at the Department of Nuclear Medicine of the University Medical Centre 
Ljubljana. TSH, free thyroxine (fT4), free triiodothyronine (fT3), TPOAb, and TgAb were 
measured with commercially available kits and the ADVIA Centaur System (Siemens 
Medical Solutions Diagnostics, Dublin, Ireland). FSH, E2, P, total T, and SHBG were 
measured by chemiluminescent immunometric assay by Immulite 2000 XPi system (Siemens 
Healthcare Diagnostics, Erlangen, Germany). Free T was calculated from total T and SHBG.  
The data are presented as mean values ± standard deviation, except for TPOAb and TgAb 
where they are presented as median (range). For the comparison of measured values between 
different groups, the Mann-Whitney U test was used. Correlations were tested using 
Kendall’s tau test. p-values below 0.05 were considered statistically significant.  
 
Results 
The healthy subject (HS) group and the AllHT group were matched by age (59.8 ± 3.9 and 
59.6 ± 4.1 years, p = 0.724), body mass index (28.5 ± 4.3 and 26.4 ± 6.1, p = 0.277), FSH 
(61.4 ± 30.2 and 63.0 ± 25.2 U/L, p = 0.668), and menopause duration (10.5 ± 5.6 and 9.9 ± 
6.1 years, p = 0.623). Levels of TPOAb and TgAb were significantly higher in the AllHT 
group in comparison to the HS group: 1300 (28–1300) kU/L and 139 (15–500) kU/L) vs. 32 
(28–45) kU/L and 15 (15–20) kU/L, respectively, p < 0.001 for both. The AllHT group also 
had significantly higher TSH level than the HS group (10.7 ± 18.4 and 2.78 ± 1.06 mU/L, p = 
0.003) as well as lower fT4 level (12.4 ± 2.6 and 14.04 ± 2.34 pmol/L, p = 0.020). The AllHT 
and HS groups did not differ significantly in fT3 level (4.51 ± 0.72 and 4.82 ± 0.61 pmol/L, p 
= 0.150). 
Sex hormone levels in the HS and AllHT groups as well as in the EuHT and Hypo HT 
subgroups are listed in Table I. No significant differences between the HS and AllHT groups 
were found. However, in the HypoHT subgroup, significantly higher free T levels were found 
than in the HS group and in the EuHT subgroup. The level of total T was significantly higher 
in the HypoHT subgroup than in the EuHT subgroup. SHBG levels were significantly lower 
in the HypoHT subgroup compared with the HS group. Subgroups did not differ with respect 
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to E2 and P levels (Tab. I). No significant correlation between sex hormone levels and 





In this prospective observational clinical study, which included two well-defined groups (HS 
and AllHT) of postmenopausal women, we found significantly higher free and total T levels 
in the HypoHT subgroup than in the EuHT subgroup. We also found significantly higher free 
T and lower SHBG levels in the HypoHT subgroup than in the HS group. Our observation is 
not in accordance with the expected anti-inflammatory influence of androgens on the 
pathogenesis of HT in postmenopausal women [4]. Because we found no significant 
correlation between higher T levels and thyroid antibodies, we speculate that the higher 
levels of T are more likely to be associated with the hypothyroid state than with HT. It was 
reported that hypothyroidism decreases plasma binding activity of SHBG, which in women 
results in decreased plasma concentrations of both total T and E2, but their unbound fractions 
are increased [5]. This is in agreement with our finding of higher free T levels in the HypoHT 
subgroup, but it does not explain the higher total T in the HypoHT group in comparison to 
the EuHT group. Of note, studies exploring the association of hypothyroidism with steroid 
hormone levels were performed several decades ago and were not reproduced with modern 
laboratory techniques; they also did not report specific data about the period of life of the 
included subjects (adolescent/adult/postmenopausal/possible PCOS etc.). Significantly lower 
SHBG levels in the HypoHT subgroup than in the HS group are in agreement with previous 
reports [5]. We found no association of HT or hypothyroid state with the E2 or P levels in 
postmenopausal women.  
A limitation of our study is a relatively small study sample. Nevertheless, the total and free T 
levels measured in our study are consistent with age-adjusted population averages and the 
variance of healthy postmenopausal women. The strengths of our study are its prospective 
nature, homogeneous well-defined groups of subjects, and analysis of thyroid and sex 




Our finding of significantly higher T levels in hypothyroid than in euthyroid postmenopausal 
women represents a novelty, which can be partly explained by the lower SHBG levels. 
Neither T nor other sex hormones seem to be associated with the occurrence of HT.  
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Table I. Sex hormone values in healthy subjects and in patients with Hashimoto’s thyroiditis.  




[n = 18] 
AllHT 
[n = 55] 
EuHT 
[n = 34] 
HypoHT 
[n = 21] 
Total T [nmol/L] 0.77 ± 0.23 0.78 ± 0.41 0.78 ± 0.23 0.81 ± 0.28b 
Free T [pmol/L] 7.13 ± 3.03 7.45 ± 4.93 7.19 ± 5.65 7.89 ± 3.55a, b 
SHBG [nmol/L] 60.09 ± 19.51 50.81 ± 21.49 54.2 ± 23.3 45.4 ± 17.4a 
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E2 [nmol/L] 0.11 ± 0.05 0.11 ± 0.06 0.10 ± 0.05 0.11 ± 0.07 
P [nmol/L] 0.64 ± 0.02 0.69 ± 0.21 0.65 ± 0.07 0.75 ± 0.32 
HS — healthy subjects; AllHT — all patients with Hashimoto’s thyroiditis; EuHT — 
euthyroid patients with Hashimoto’s thyroiditis; HypoHT — hypothyroid patients with 
Hashimoto’s thyroiditis; T — testosterone; SHBG — sex hormone-binding globulin; E2 — 
oestradiol; P — progesterone; ap < 0.05 when compared with HS; bp < 0.05 when compared 
with EuHT 
